21 Jun, 2018 2018 Summer RNAi Roundtable Series
We are hosting a series of online “RNAi Roundtables” from June through September, at which Alnylam scientists, clinical collaborators, and patients or patient advocates review recent progress in many of the Company’s late-stage pipeline programs and discuss the related disease areas.
Click on any of the RNAi Roundtables below to listen to the webcasts and view presentations from these events.
Platform Advances in RNAi Therapeutics
Tuesday, June 26, 10:30 am ET
Givosiran, in Development for the Treatment of Acute Hepatic Porphyrias
Tuesday, July 24, 10:00 am ET
Lumasiran, in Development for the Treatment of Primary Hyperoxaluria Type 1
Wednesday, August 15, 10:30 am ET
Patisiran & ALN-TTRsc02, for the Treatment of Transthyretin-Mediated Amyloidosis
Tuesday, September 11, time TBD
